Evidence map›Paper›PMID 32735326›Full record

ReviewQJM : monthly journal of the Association of Physicians2021

Potential role of hypovitaminosis D and vitamin D supplementation during COVID-19 pandemic.

M Verdoia, G De Luca

Open access · bronzeAbstract readReview
In one paragraph

Review in QJM : monthly journal of the Association of Physicians, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. COVID-19 and community self-prescribing: a dangerous folly.QJM : monthly journal of the Association of Physicians · 2021
    Article
  12. Article
  13. Article
  14. Vitamin D and COVID-19: It is time to act.International journal of clinical practice · 2021
    Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

M VerdoiaDepartment of Cardiology, Ospedale degli Infermi, ASL Biella, Biella, Italy.
G De LucaDepartment of Cardiology, AOU Maggiore della Carità, Università del Piemonte Orientale, Corso Mazzini, 18, 28100 Novara, Italy.
Ospedale degli Infermi · ITUniversità degli Studi del Piemonte Orientale “Amedeo Avogadro” · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vitamin D deficiency is a pandemic disorder affecting over 1 billion of subjects worldwide and displaying a broad spectrum of implications on cardiovascular and inflammatory disorders. Since the initial reports of the association between hypovitaminosis D and COVID-19, Vitamin D has been pointed as a potentially interesting treatment for SARS-CoV-2 infection. We provide an overview on the current status of vitamin D deficiency, the mechanisms of action of vitamin D and the current literature on the topic, with a special focus on the potential implications for COVID-19 pandemic.

Indexed as

COVID-19Vitamin DVitamin D DeficiencyDietary SupplementsHumansSARS-CoV-2VitaminsVitamin DVitamins

Identifiers

PMID32735326
PMCPMC7454841
OpenAlexW3046726264

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.